After analyzing the tumor sizes and weight, the results showed that overexpression of METTL3 significantly potentiated allograft growth of cervical cancer in vivo, which increased both tumor sizes and tumor weight (Figure 7A–C), confirming the cancer‐promoting role of METTL3 in cancer progression. The gene discussed is METTL3; the disease is cervical carcinoma.